Hanchang Loses Loan Lawsuit to Icare… Ordered to Pay KRW 1.27 Billion Equaling 12.07% of Equity

The Seoul Central District Court ruled that Hanchang must jointly pay KRW 1,273,347,942 plus overdue interest to Icare Corporation.
The judgment amount represents 12.07% of Hanchang's equity based on capital, imposing a massive debt burden that will severely impair the company's financial health.
Despite already being in a capital impairment state, Hanchang now faces additional liabilities, amplifying concerns about existing shareholder value dilution.
Hanchang plans to respond through legal counsel including appeal, but the judgment is enforceable immediately upon finalization, likely deteriorating cash flow.
[AI Summary]This loan lawsuit loss exposes Hanchang to a debt exceeding 12% of its equity. Given its capital impairment, financial damage is inevitable without new funding or asset sales, which is a negative factor for the stock price.